This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a Comeback

  • A few years ago, Pfizer (PFE -2.86%) was on top of the world when it came to earnings and stock price performance. The pharma giant recorded a record of $100 billion in sales back in 2022, and saw its shares rise 60% over nearly two years through a peak in late 2021.